Glaxosmithkline

“Lucozade and Ribena are iconic brands that have made a huge contribution to GSK over the years, but now is the right time to sell them...

SOLD! GSK exits drinks market

Glaxo sells Lucozade and Ribena to Suntory for £1.35bn cash

By Shane STARLING

Ever-expanding Japanese beverage behemoth, Suntory, is the new owner of Lucozade and Ribena, which GlaxoSmithKline (GSK) has sold for £1.35bn (€1.6bn/$2.11bn) as it admits defeat in its internationalisation plans and trains its focus on its pharma activities.

Spotlight

Follow us

Products

View more

Webinars

Food & Beverage Trailblazers Podcast

F&B Trailblazers Podcast

Featured Suppliers

All suppliers